Alkyne–quinuclidine derivatives as potent and selective muscarinic antagonists for the treatment of COPD

Abstract SAR around alkyne–quinuclidine derivatives allowed the discovery of highly potent muscarinic antagonists displaying interesting preferential slow off-rates from the M3 receptor.